Related Experiment Video
Updated: Mar 15, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced
Michael I Carr1, Justine E Roderick2, Hugh S Gannon1
1Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Abstract:
ATM phosphorylation of Mdm2-S394 is required for robust p53 stabilization and activation in DNA-damaged cells. We have now utilized Mdm2(S394A) knockin mice to determine that phosphorylation of Mdm2-S394 regulates p53 activity and the DNA damage response in lymphatic tissues in vivo by modulating Mdm2 stability. Mdm2-S394 phosphorylation delays lymphomagenesis in Eμ-myc transgenic mice, and preventing Mdm2-S394 phosphorylation obviates the need for p53 mutation in Myc-driven tumorigenesis. However, irradiated Mdm2(S394A) mice also have increased hematopoietic stem and progenitor cell functions, and we observed decreased lymphomagenesis in sub-lethally irradiated Mdm2(S394A) mice. These findings document contrasting effects of ATM-Mdm2 signaling on p53 tumor suppression and reveal that destabilizing Mdm2 by promoting its phosphorylation by ATM would be effective in treating oncogene-induced malignancies, while inhibiting Mdm2-S394 phosphorylation during radiation exposure or chemotherapy would ameliorate bone marrow failure and prevent the development of secondary hematological malignancies.
Insights
Phosphorylating Mdm2 at S394 by ATM stabilizes p53, crucial for DNA damage response. This phosphorylation delays lymphoma in mice, but inhibiting it aids bone marrow recovery after radiation.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Signaling
Background:
- ATM-Mdm2 signaling is critical for p53 stabilization and activation following DNA damage.
- Mdm2 phosphorylation at serine 394 (S394) by ATM is a key regulatory step.
- The in vivo role of Mdm2-S394 phosphorylation in the DNA damage response and tumorigenesis remains to be fully elucidated.
Purpose of the Study:
- To investigate the in vivo function of Mdm2-S394 phosphorylation in regulating p53 activity and DNA damage response.
- To determine the impact of Mdm2-S394 phosphorylation on lymphomagenesis and tumorigenesis.
- To explore the therapeutic potential of modulating ATM-Mdm2 signaling in cancer and radiation therapy.
Main Methods:
- Utilized Mdm2(S394A) knockin mice to study the effects of preventing Mdm2-S394 phosphorylation.
- Assessed p53 stabilization and activation in DNA-damaged cells and lymphatic tissues.
- Evaluated lymphomagenesis in Eμ-myc transgenic mice crossed with Mdm2(S394A) mice.
- Analyzed hematopoietic stem and progenitor cell function in irradiated Mdm2(S394A) mice.
Main Results:
- Mdm2-S394 phosphorylation regulates p53 activity and DNA damage response in lymphatic tissues by modulating Mdm2 stability.
- Preventing Mdm2-S394 phosphorylation delays lymphomagenesis in Eμ-myc transgenic mice and obviates the need for p53 mutation.
- Irradiated Mdm2(S394A) mice exhibit increased hematopoietic stem and progenitor cell function and decreased lymphomagenesis.
Conclusions:
- ATM-mediated Mdm2-S394 phosphorylation plays a dual role in tumor suppression and DNA damage response.
- Destabilizing Mdm2 via ATM phosphorylation is a potential therapeutic strategy for oncogene-induced malignancies.
- Inhibiting Mdm2-S394 phosphorylation could mitigate bone marrow failure and prevent secondary malignancies after radiation or chemotherapy.
More Related Videos
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Mitogens and the Cell Cycle

